Kontext: Mykotické aneurysma mozkových tepen (cerebral mycotic aneurysm, CMA) na podkladě infekční endokarditidy (IE) se vyskytuje vzácně. Klinické projevy této patologické jednotky dosud nebyly přesně popsány. Metody: Zdrojem údajů pro tuto studii byla komplexní rešerše literatury publikované v angličtině v letech 1990-2014 v databázích PubMed, Highwire Press a vyhledávacího stroje Google (Google search engine). Vyhledávanými termíny byly "infekční endokarditida" a "intrakraniální mykotické aneurysma/mykotické aneurysma mozkových tepen". Výsledky: Ke vzniku CMA obvykle docházelo v průběhu 2,1 měsíce od rozvoje IE. Nejčastějším patogenem byl Staphylococcus; kultivací krevních vzorků byla zjištěna i přítomnost streptokoků. Nejčastějším projevem při vyšetření výpočetní tomografi í bylo intraparenchymální krvácení. Spolehlivým diagnostickým nástrojem pro přesné určení místa aneurysmatu je angiogram. Nejčastěji postiženou cévou byla střední mozková tepna, následována zadní mozkovou tepnou. I když bylo u většiny pacientů nutno provést intervenční nebo chirurgickou léčbu CMA, u některých postačila konzervativní léčba. Jednorozměrová analýza prokázala, že významnými predikčními rizikovými faktory spojenými se zvýšenou mortalitou byly rozvoj herniace, postižení mateřské cévy, ruptura aneurysmatu a nechirurgická/neintervenční léčba aneurysmat. Závěr: Vzhledem k možným důsledkům vzniku cefalokély a ruptury aneurysmatu představují CMA značné riziko. Léčba této patologické jednotky je vždy náročná, protože načasování operačních výkonů na mozku a na srdci se kvůli nutné heparizinaci při kardiochirurgických výkonech obtížně plánuje. Pacientům s IE je nutno v prevenci případných důsledků tohoto onemocnění, např. tvorby CMA, podávat antibiotika v dostatečných dávkách. Volba léčby CMA závisí na aktuální situaci. U vybraných pacientů je lze řešit konzervativně, endovaskulárně nebo chirurgicky. U pacientů s rupturou CMA se doporučuje mezi zasvorkováním nebo chirurgickou excizí aneurysmatu a kardiochirurgickým výkonem dodržet odstup nejméně dvou týdnů.
Introduction
Neurological consequences including stroke or transient ischemic attack, cerebral hemorrhage, mycotic aneurysm, meningitis, cerebral abscess, or encephalopathy remain a signifi cant problem of infective endocarditis (IE) [1] . Neurologic complications were signifi cantly associated with Staphylococcus aureus infection and with IE affecting both the aortic and the mitral valves [2, 3] . Staphylococcus aureus endocarditis increases the risk of neurologic morbidity and mortality [4] . Of these, cerebral mycotic aneurysm (CMA) secondary to IE is at any rate exiguous but potentially fatal. In particular, symptomatic CMAs are uncommon [5] . One to two percent of patients with native valve infective endocarditis have CMAs [5] . However, there have been no popularly accepted regimens for the management of CMAs [6] . This study aims to present the clinical features, diagnosis, treatment and prognosis of CMAs as a consequence of IE.
Methods
Comprehensive retrieval of the literature was made in the PubMed, Highwire Press and Google search engine for the year range 1990 to 2014. The search terms included "infective endocarditis" and "intracranial/cerebral mycotic aneurysm". The search ended on August 31, 2014. Only articles published in English language were retained. Duplicate publications and articles describing the patients with mycotic aneurysm of other arteries were excluded from the statistical analysis.
Data were extracted from the text, fi gures, or tables and included details of the study population, demographics, pathologies of IE and CMA, diagnosis, management strategies, prognosis and follow-up.
Measurement data were expressed in mean ± standard deviation with range and median values and were compared by independent sample t-test. Categorical variables were compared by Fisher exact test. Univariant analysis was made to assess the predictive risk factors associated with an increased mortality of this patient setting. p < 0.05 was considered statistically signifi cant.
Results
A total of 68 articles were collected with 149 patients involved. Gender was not indicated in 21 patients. Of the remaining 128 patients, 83 (64.8%) were males and 45 (35.2%) were females with a male-to-female ratio of 1.84:1. Their ages were 35.9 ± 17.0 (range, 1-87; median, 35) years (n = 117).
The duration of IE symptoms was 2.1 ± 2.3 (range, -0.75-6; median, 1.2) months (n = 8) (the minus symbol represented an onset of symptom after admission; the same below).
The major clinical symptoms of IE were described in 45 patients with fever in 42 (93.3%) and chest distress, chest pain and fatigue in 1 (2.2%) patient each. A heart murmur was audible in 33 patients with a systolic murmur in 22 (66.7%) (one of them has a S 3 ), a diastolic in 2 (6.1%), both systolic and diastolic in 6 (18.2%) and unknown in 3 (9.1%). Eight patients had a signifi cant medical history including postpartum (3 days after delivery), left MCA infarct associated with Down's syndrome and endocardial cushion, aortic valvulotomy for aortic stenosis, previous IE, mitral regurgitation, mitral valve prolapse, mitral valvotomy, right intracerebral aneurysm thrombosis with residual aphasia and right hemiparesis in 1 each.
Results: The CMAs usually developed 2.1 months after the onset of IE. Staphylococcus was the most frequent pathogen and Streptococcus was more frequent as evidenced by blood culture. The most common presentation on computed tomography was intraparenchymal hemorrhage. Angiogram was a reliable diagnostic means for determining the location of the aneurysm. The middle cerebral artery was the most commonly affected and the posterior cerebral artery was more commonly affected. Interventional or surgical treatments of the CMAs were required in most patients, while some were recovered under conservative treatment. Univariant analysis revealed the development of herniation, parent vessel involvement, aneurysm rupture and non-surgical/interventional treatment of the aneurysms were signifi cant predictive risk factors associated with increased mortality.
Conclusion:
The CMAs are risky due to their potential consequences of cerebral hernia and aneurysmal rupture. The treatment of this entity is always challenging as it is diffi cult to determine the timing of the cerebral and cardiac operations concerning the necessity of heparinization in cardiac surgery. Suffi cient antibiotics have to be used in IE patients in order to prevent from the potential consequence as CMAs. The choices of treatment for CMAs depend on the conditions of CMAs. They are curable to either conservative, endovascular or surgical management in selected patients. At least 2-week interval between clipping or surgical excision of the aneurysm and the cardiac procedure is recommended in patients with a ruptured CMA. Blood cultures were described in 89 patients. Nine (10.1%) patients had a negative result (however culture of cerebral hematoma grew Streptococcus viridians in 1 patient) while 80 (89.9%) were positive. Staphylococcus was the most frequent pathogen followed by Streptococcus. The microbial spectrum was shown in Table 1 .
Keywords:
In 39 patients, preoperative antibiotics were use including penicillin in 10 (25.6%), ampicillin in 7 (17.9%), vancomycin in 3 (7.7%), ceftriaxone in 3 (7.7%) and antibiotics unspecifi ed in 16 (41.0%) patients. Gentamycin was jointly used with other antibiotics in 16 patients. One of the patients was also given rifampin. The antibiotic treatment lasted 4.4 ± 2.8 (range, 0.4-14; median, 5.9) weeks (n = 50).
Neurological onset symptoms were described in 79 patients. Headache was the most frequent symptom followed by hemiparesis ( Table 2 ). The onset time was given for 40 patients. It was described as "sudden", "acute", or "recurrent" in 16 patients. In the remaining 24 patients, the duration of the symptoms was 0.4 ± 1.5 (range, -1.25-4; median, -0.15) months (n = 24) (13 patients had an onset after admission). The time interval between onsets of IE and CMA was 2.1 ± 2.5 (range, 0-12; median, 1.4) months (n = 32).
127 patients had 140 episodes of CMAs with 104 (81.9%) having 1 episode, 9 (7.1%) had 2 episodes, 1 (Fig. 1) . Of them, 64 (84.2%) patients had a solitary vegetation while 12 (15.8%) had multiple vegetations ( 2 = 71.2, p = 0.000). Dimensions of 9 vegetations from 7 patients were recorded with a mean of 13.4 ± 5.2 (range, 6-20; median, 13) mm (n = 9). The valvular pathologies secondary to IE were mitral regurgitation in 19 (65.5%), mitral regurgitation in 5 (17.2%), and aortic regurgitation and stenosis, aortic and mitral regurgitation, mitral regurgitation and stenosis, mitral valve prolapse and mitral and tricuspid prolapse in 1 (3.4%) patient each.
(0.8%) had 3 episodes. Cerebral computed tomography or alternative imaging manifestations of these patients revealed intracranial hemorrhage was the most common (Table 3) . Eleven (9.6%) patients present with midline shift namely herniation.
CMAs on angiogram were reported for 143 patients. The affected cerebral artery was not indicated in 33 patients. Of the remaining 110 patients, CMAs involved one vessel in 96 (87.3%), 2 vessels in 13 (11.8%) and 3 vessels in 1 (0.9%) patient. A single aneurysm developed in one or more vessels in 98 (89.9%), 2 aneurysms in one vessel in 7 (6.4%) patients and 3 or more aneurysms in one vessel in 4 (3.7%) patients, respectively. MCA was the most commonly affected artery and posterior cerebral artery was more commonly affected (Table 4 ). In 2 (1.4%) patients, the CMAs involving the MCA were pseudoaneurysms. The cerebral arteries affected by CMAs were reported in 73 patients. They were on the right in 35 (47.9%), left in 32 (43.8%) and bilateral in 6 (8.2%). The locations of 117 aneurysms of 102 patients were stated, and most of them were located at the distal portion of the arteries (Table  5 ). Totally 42 aneurysms of 32 patients ruptured (one of the aneurysms ruptured twice).
Dimensions of 49 aneurysms of 43 patients were recorded with a mean of 6.7 ± 6.6 (range, 1-40; median, 5) mm (n = 49). Three aneurysms of 2 patients progressed during hospitalization with an increment of 4 mm, 2 mm and 3.2 mm respectively. Shapes of the aneurysms were reported for 14 aneurysms in 12 patients: 5 (35.7%) were saccular, 4 (28.6%) were fusiform, 2 (14.3%) were multilobed and 1 (7.1%) each was opercular, pear-shaped and irregular, respectively.
Of the conservative treatment group, 16 patients received antibiotics and 1 patient received aminocaproic acid and phenytoin sodium treatment instead of antibiotics and the aneurysm decreased in size. The time interval for the antibiotics to take effect was 6.3 ± 2.5 (range, 3-12; median, 6) weeks (n = 9). Nine patients only had decompressive craniotomy with the CMAs without being intervened. In the interventional and surgical groups, effects of antibiotics prior to intervention were described in 13 patients for their 15 aneurysms as resolution in 1 (6.7%), decrease in size in 2 (13.3%), no change in 3 (20%), increase in size in 3 (20%) and unspecifi ed in 6 (40%) aneurysms (Table 6 ). In a patient with 3 CMAs, one CMA showed complete resolution and one CMA decreased in size following antibiotic treatment but the third aneurysm necessitated an interventional therapy. In another patient, antibiotic treatment dwindled one of his 2 CMAs and the other enlarged aneurysm was coiled successfully. Another 2 patients had 3 and 2 CMAs respectively, and all of which were successfully interventionally treated. Of them, 3 (5.4%) patients had twice interventions due to recurrent aneurysms. Totally 62 aneurysms of 56 patients were interventionally treated (Table 7 ). In the interventionally treated patients, the parent vessel was sacrifi ced in 5 (8.9%) patients. Two (3.6%) patients had hematoma 
Discussion
Mycotic aneurysms are rare infl ammatory neurovascular lesions, comprising 0.7-5.4% of all intracranial aneurysms. Sixty fi ve percent of CMA patients have an underlying IE etiology. Other common sources of infection are intravenous drug abuse (6.3%), bacterial meningitis (5.2%), poor dental hygiene (4.2%) and cavernous sinus thrombosis (2.8%) [75] .
CMAs occur more frequently in the course of acute IE rather than in the subacute course [76] . Streptococcus viridans and Staphylococcus aureus are the most common organisms that cause infective endocarditis. As a result they also are the two pathogens most frequently associated with CMA, a complication of IE [6] . CMAs develop secondary to IE when cardiac vegetations are friable prone to septic emboli lodging into the intracranial vessels usually the branches [42] . Pathological studies of the cerebral aneurysm revealed a large number of neutrophils invading arterial walls. The diagnosis of mycotic aneurysm and bacterial vasculitis was supported by the presence of IE [56] . Histopathology of the biopsy specimen showed acute or chronic infl ammatory lesion with granulation tissue formation, blood clot and organizing thrombus [77] . The acute infl ammation leads to neutrophils infi ltration followed by degradation of the media and adventitia, fragmentation of the internal elastic lamina and proliferation of the intima. The weakened vessel wall in combination with the pulsatile pressure in the vasculature leads to an aneurysm formation and consequential growth [75] . Cytokines and the formation abnormality of collagen fi bers are liable to aneurysmal formation [51] . As silent CMAs are pending to rupture and thus potentially lethal, cerebral angiographic studies are recommended in patients with IE [78] . Typically CMAs are multiple, distal, and fusiform aneurysms, but the angiographic and clinical presentations can vary signifi cantly. The most common presentation of CMA is intracranial hemorrhages [6] . Computed tomography scan, magnetic resonance imaging and digital subtraction angiography are the commonly used imaging procedures in CMA. The important imaging fi ndings are subarachnoid hemorrhage or intracerebral hemorrhage in a patient with ruptured CMA [79] . Other fi ndings may include infarct, edema, hydrocephalus, or rarely subdural hematomas [6] . Digital subtraction angiography confi rmed the diagnosis, delineated anatomical details and later detected the complete resolution of the aneurysm following conservative management with intravenous antimicrobial agents [6] . Septic infarct is more common than intraparenchymal hemorrhage where the bleeding can be subarachnoid, intraparenchymal, or intraventricular [75] .
Unruptured CMA may have a spontaneous obliteration in most cases [8] . The management of a CMA depends on the presence or absence of hemorrhage, anatomic location and clinical course [80] . As antimicrobial therapy may take effect for CMAs, conservative regimens are therefore preferred in some institutes [60] . Endovascular techniques are popularly recognized for the management of all types of CMAs. The advantages of endovascular therapy over surgery are a decreased risk of anesthesia, rapid anticoagulation therapy and avoidance of delay for aneurysmal treatment and cardiac surgery. A major indication for endovascular therapy would be a patient with high surgical risk, a patient candidate for cardiac surgery [75] , and a surgically inaccessible or multiple CMAs [15] . The choice between open surgery and endovascular management and between preservation and sacrifi ce of the parent vessel depends primarily on a multiple factors including the morphology and location of the aneurysm [75] . In patients with intracranial hemorrhage, surgery should be postponed for 2-3 weeks [1] . Some author recommended postponing it for 4-6 weeks [81] . CMAs with a well-defi ned neck can be subjected to direct clipping [49] . Endovascular treatment is recommended for CMAs, if there is no severe mass effect [1] . Endovascular coiling has been successfully performed as early as 1 day before valve replacement [82] .
The timing of cardiac surgery is sometimes diffi cult to determine as heparinization and hypotension during cardiopulmonary bypass or postoperative anticoagulant therapy are liable to amplify the cerebral damage [7] . Cardiac surgery within 3 days is indicated for the patients with severe heart failure, uncontrolled infection, abscess, or persisting high emboli risk; otherwise a 4-week delay is warranted [83] . If bacteremia and cardiac failure can be controlled, antibiotic regimens and the direct attachment of clips may be effective therapies [24] . An interval of 2-3 weeks between clipping or surgical excision of the aneurysm and the cardiac procedure is recommended in patients with ruptured CMAs [66] . It was hypothesized that introducing the foreign material into the CMA may increase the opportunity of infection and rupture [84] . However, no postprocedural infections or abscesses were found in the interventionally treated patients [75] . Comparisons between surgical clipping and endovascular treatment showed that coiling was associated with a better outcome [85] . Ruptured CMAs are generally managed by surgery. The commonly used procedures are clipping, trapping, anastomosis and proximal ligation [6] . Patients with ruptured aneurysm with hematoma and mass effect would require urgent surgery [6] .
The prognosis of these patients depends on the prompt recognition and early aggressive treatment. Both endovascular and surgical techniques are safe and effective options that have been shown to increase survival when compared to conservative management alone [82] . Follow-up angiographic results were better with clipping, as total aneurysm occlusion was 81.4% of the patients in comparison to 57.5% in the patients with coiling [86] . Technical success (aneurysm occlusion without rupture or recanalization) and clinical success (no neurologic complication attributable to the intervention) were obtained equally endovascularly and neurosurgically [82] . Anticoagulation needed reversal before craniotomy for clipping after valve replacement [82] .
Conclusions
The CMA is infrequent, and it is rare as a consequence of IE. The CMAs are risky due to their potential consequences of cerebral hernia and aneurysmal rupture. The treatment of this entity is always challenging as it is difficult to determine the timing of the cerebral and cardiac operations concerning the necessity of heparinization in cardiac surgery. Management of multiple or recurrent CMAs is even more complex considering the diverse choices of treatment in relation to the locations, sizes and time of occurrence of the CMAs. The CMAs are curable to either conservative, interventional, or surgical treatment in selected patients. Cardiac operation should be postponed unless there is severe heart failure. At least a 2-week interval between clipping or surgical excision of the aneurysm and the cardiac procedure is recommended in patients with a ruptured CMA. Sufficient antibiotics have to be used in IE patients in order to prevent from the potential consequence as CMAs.
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